지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.10
- 수록면
- 1 - 12 (12page)
- DOI
- 10.1038/s12276-021-00683-y
이용수
초록· 키워드
오류제보하기
Fabry disease is an X-linked lysosomal storage disease caused by a mutation in the galactosidase alpha (GLA) gene. Despite advances in therapeutic technologies, the lack of humanized experimental models of Fabry disease has limited the development of new therapies to cure the disease. Herein, we modeled Fabry disease using human inducible pluripotent stem cell (iPSC)-derived kidney organoids and the CRISPR?Cas9 genome-editing system. GLA-mutant human kidney organoids revealed deformed podocytes and tubular cells with accumulation of globotriaosylceramide (Gb3). Ultrastructural analysis showed abundant electron-dense granular deposits and electron-dense lamellate lipid-like deposits that formed concentric bodies (zebra bodies) in the cytoplasm of podocytes and tubules. The oxidative stress level was increased in GLA-mutant kidney organoids, and the increase was accompanied by apoptosis. Enzyme replacement treatment (ERT) with recombinant human α-Gal A decreased the Gb3 accumulation and oxidative stress, which resulted in amelioration of the deformed cellular structure of the GLA-mutant kidney organoids. Transcription profile analyses showed decreased glutathione (GSH) metabolism in GLA-mutant kidney organoids. GSH replacement treatment decreased oxidative stress and attenuated the structural deformity of the GLA-mutant kidney organoids. GSH treatment also increased the expression of podocyte and tubular markers and decreased apoptosis. In conclusion, GLA-mutant kidney organoids derived from human iPSCs are valuable tools for studying the mechanisms and developing novel therapeutic alternatives for Fabry disease.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip
Nano Convergence
2021 .11
-
Methods in organoids: a model that goes beyond our imagination
Experimental and Molecular Medicine
2021 .10
-
Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives
조직공학과 재생의학
2024 .07
-
Recent advances in organoid culture for insulin production and diabetes therapy: methods and challenges
BMB Reports
2019 .01
-
Recent Progress and Future Perspectives on Intestinal Organoids in Livestock
농업생명과학연구
2021 .10
-
Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches
Experimental and Molecular Medicine
2020 .02
-
Organoids in image-based phenotypic chemical screens
Experimental and Molecular Medicine
2021 .10
-
Development of bioinformatics and multi-omics analyses in organoids
BMB Reports
2023 .01
-
Strategies for genetic manipulation of adult stem cell-derived organoids
Experimental and Molecular Medicine
2021 .10
-
Biobanking of human gut organoids for translational research
Experimental and Molecular Medicine
2021 .10
-
Stem cells, organoids and their applications for human diseases: Special issue of BMB Reports in 2023
BMB Reports
2023 .01
-
Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers
BMB Reports
2023 .01
-
Organoids as host models for infection biology ? a review of methods
Experimental and Molecular Medicine
2021 .10
-
Liver Organoids: Formation Strategies and Biomedical Applications
조직공학과 재생의학
2021 .01
-
Fabrication of kidney derived ECM bioink based construct for renal tissue regeneration using kidney organoids
대한기계학회 춘추학술대회
2020 .08
-
Applications of Organoids for Tissue Engineering and Regenerative Medicine
조직공학과 재생의학
2020 .01
-
Development of High-throughput Versatile iPSC-based Organoid Platform Using 3D Bioprinting
한국고분자학회 학술대회 연구논문 초록집
2023 .04
-
Current status and prospects of organoid-based regenerative medicine
BMB Reports
2023 .01
-
The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases
Experimental and Molecular Medicine
2023 .02
-
Evaluation of Intestinal Epithelial Barrier Function in Inflammatory Bowel Diseases Using Murine Intestinal Organoids
조직공학과 재생의학
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0